ZEISS Professional Education

Marion R. Munk, MD, PhD

A discussion on OCT & Retina Forum.

Caroline R. Baumal, MD

A discussion on OCT Angiography (OCT-A) Imaging in Proliferative Diabetic Retinopathy (PDR).

Michael Chaglasian, OD, FAAO

Optometry is frequently the first line of defense in detecting, diagnosing, and managing disease; especially within the scope of Glaucoma. Though Glaucoma is a slow progressing disease, it is imperative that we detect and manage a patient prior to substantial nerve or field loss occurring. Multiple data points are necessary to properly manage Glaucoma. One of the fundamental ways of doing this and a gold standard is utilizing diagnostic testing such as visual field testing.

James Armitage, BOptom, CertOcTher (ACO), MOptom, PhD, FAAO, FACO

As optometrists we are often the health practitioners that see our patients regularly and are responsible for the detection, diagnosis and, depending on jurisdiction, management of glaucoma. Ideally, we want to detect and manage as early as possible in the disease process, prior to extensive nerve or field loss but this generates significant diagnostic uncertainty because glaucoma is usually a slow progressing disease and the early signs are subtle. In this space, OCT, OCT-A and the trend-based analysis of dense data cubes can provide us with the information required to inform our diagnostic decision making, improving patient outcomes.

Craig McArthur

The session will showcase how ZEISS Glaucoma Workplace can be used as the centerpiece of a busy glaucoma clinic within a community optometric clinic. Case histories will be used to illustrate how Glaucoma Workplace helps minimize testing times through an efficient patient journey whilst maximizing data-driven patient care.